ArticleMolecular medicine reports2019

Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway.

Yafei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.